lisuride has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, V; Chaturvedi, S; Misra, DP; Prasad, N; Rai, MK; Rastogi, K; Singh, H | 1 |
| Gong, Q; Huang, C; Huang, J; Li, G | 1 |
| Allanore, Y; Bruni, C; Distler, O; Gabrielli, A; Iannone, F; Matucci-Cerinic, M; Praino, E | 1 |
2 review(s) available for lisuride and Cirrhosis
| Article | Year |
|---|---|
Relationships between serotoninergic system and skin fibrotic.
Topics: Animals; Cell Growth Processes; Dopamine Agonists; Fibrosis; Humans; Lisuride; Precision Medicine; Receptor, Serotonin, 5-HT1A; Scleroderma, Systemic; Selective Serotonin Reuptake Inhibitors; Serotonin; Skin | 2014 |
Use of biologics and other novel therapies for the treatment of systemic sclerosis.
Topics: Abatacept; Acetamides; Antibodies, Monoclonal, Humanized; Biological Products; Clinical Trials as Topic; Fibrinolytic Agents; Fibrosis; Humans; Hypertension, Pulmonary; Indoles; Inflammation; Joints; Lisuride; Lung; PubMed; Pyrazines; Pyrazoles; Pyrimidines; Scleroderma, Systemic; Skin | 2017 |
1 other study(ies) available for lisuride and Cirrhosis
| Article | Year |
|---|---|
5-HT
Topics: Adult; Cells, Cultured; Extracellular Matrix Proteins; Extracellular Signal-Regulated MAP Kinases; Female; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Indoles; Lisuride; Phenotype; Phosphorylation; Receptor, Serotonin, 5-HT2B; Scleroderma, Systemic; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Skin; STAT3 Transcription Factor; Transforming Growth Factor beta1; Urea | 2018 |